Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 1386.00 | 3816.00 | 0.3632 | -0.0243 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 3318.00 | 3816.00 | 0.8695 | 0.8113 | |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 6545.00 | 7055.25 | 0.9277 | 0.8901 | |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 6662.00 | 7055.25 | 0.9443 | 0.9155 | |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 5000.00 | 2808.68 | 6710.00 | 7055.25 | 0.9511 | 0.9259 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 5000.00 | 2808.68 | 7055.00 | 7055.25 | 1.0000 | 1.0000 |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 5000.00 | 2808.68 | 7091.00 | 7055.25 | 1.0051 | 1.0076 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 5000.00 | 2808.68 | 6618.00 | 7055.25 | 0.9380 | 0.9060 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 5000.00 | 2808.68 | 3383.00 | 7055.25 | 0.4795 | 0.1503 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 5000.00 | 2808.68 | 6827.00 | 7055.25 | 0.9677 | 0.9511 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 5000.00 | 2808.68 | 7026.00 | 7055.25 | 0.9959 | 0.9938 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7470.00 | 7055.25 | 1.0588 | 1.0879 | |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 5000.00 | 2808.68 | 2422.00 | 7055.25 | 0.3433 | -0.1055 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 5000.00 | 2808.68 | 6608.00 | 7055.25 | 0.9366 | 0.9038 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 6791.00 | 7055.25 | 0.9626 | 0.9434 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 7559.00 | 7055.25 | 1.0714 | 1.1065 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 5000.00 | 2808.68 | 6936.00 | 7055.25 | 0.9831 | 0.9745 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 7308.00 | 7055.25 | 1.0358 | 1.0537 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 7076.00 | 7055.25 | 1.0029 | 1.0044 |
| BT-20 | Erlotinib | 1 | uM | 9 | 5000.00 | 2808.68 | 5370.00 | 7055.25 | 0.7611 | 0.6286 |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 5000.00 | 2808.68 | 7195.00 | 7055.25 | 1.0198 | 1.0297 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 5000.00 | 2808.68 | 4968.00 | 7055.25 | 0.7042 | 0.5360 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 2097.00 | 7055.25 | 0.2972 | -0.1974 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 6958.00 | 7055.25 | 0.9862 | 0.9792 | |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7016.00 | 7055.25 | 0.9944 | 0.9916 |